Helius Medical Technologies Stock Fundamentals
| HSDT Stock | USD 0.41 0.02 4.65% |
Helius Medical Technologies fundamentals help investors to digest information that contributes to Helius Medical's financial success or failures. It also enables traders to predict the movement of Helius Stock. The fundamental analysis module provides a way to measure Helius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Helius Medical stock.
At this time, Helius Medical's Reconciled Depreciation is comparatively stable compared to the past year. Helius | Select Account or Indicator |
Helius Medical Technologies Company Operating Margin Analysis
Helius Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Helius Medical Operating Margin | (79.80) % |
Most of Helius Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Helius Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Helius Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Helius Medical Technologies has an Operating Margin of -79.8039%. This is 127.49% higher than that of the Health Care Equipment & Supplies sector and 103.01% higher than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Helius Medical Techn Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Helius Medical's current stock value. Our valuation model uses many indicators to compare Helius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Helius Medical competition to find correlations between indicators driving Helius Medical's intrinsic value. More Info.Helius Medical Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Helius Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Helius Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Helius Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Helius Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics of similar companies.Helius Medical is currently under evaluation in operating margin category among its peers.
Helius Fundamentals
| Return On Equity | -2.6 | ||||
| Return On Asset | -1.13 | ||||
| Operating Margin | (79.80) % | ||||
| Current Valuation | (1.13 M) | ||||
| Shares Outstanding | 5.67 M | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 6.63 % | ||||
| Number Of Shares Shorted | 55.52 K | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 4.61 X | ||||
| Revenue | 644 K | ||||
| Gross Profit | (16 K) | ||||
| EBITDA | (12.11 M) | ||||
| Net Income | (8.85 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 57 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (10.42 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (4.27) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 2.31 M | ||||
| Total Asset | 7.69 M | ||||
| Retained Earnings | (159.96 M) | ||||
| Working Capital | 5.56 M | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
| Net Asset | 7.69 M |
About Helius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Helius Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 38.7 K | 36.8 K | |
| Total Revenue | 740.6 K | 458.8 K | |
| Cost Of Revenue | 670.5 K | 704 K | |
| Stock Based Compensation To Revenue | 2.91 | 4.51 | |
| Sales General And Administrative To Revenue | 32.41 | 28.81 | |
| Research And Ddevelopement To Revenue | 5.25 | 10.01 | |
| Capex To Revenue | 0.05 | 0.05 | |
| Revenue Per Share | 1.22 | 1.16 | |
| Ebit Per Revenue | (17.37) | (18.24) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.